PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog ®/NovoRapid® in Healthy Males
Condition: Diabetes Mellitus, Type 1 Intervention: Drug: Gan & Lee Insulin Aspart Sponsor: Gan and Lee Pharmaceuticals, USA Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2020 Category: Research Source Type: clinical trials
